## NXPI: NXP Semiconductors N.V. - XLK: Technology

### Executive Summary

No thesis match: PEG 1.27 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-2.3% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($218.47)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 7
- **Sentiment:** Bullish (Bullish: 2, Bearish: 0)

**1. Public Sector Pension Investment Board Has $30.19 Million Position in NXP Semiconductors N.V. $NXPI**
- Source: MarketBeat | 20251214T104947 | Somewhat-Bullish | Relevance: 100%
- The Public Sector Pension Investment Board significantly increased its stake in NXP Semiconductors N.V. by 250.4% in Q2, acquiring 138,184 shares valued at $30.19 million. NXP reported solid financial metrics, despite slightly missing EPS estimates, and analysts maintain a "Moderate Buy" consensus with an average price target of $260.04. The semiconductor company also declared a quarterly dividend of $1.014 per share, demonstrating consistent returns for investors.

**2. 12,033 Shares in NXP Semiconductors N.V. $NXPI Acquired by Shorepoint Capital Partners LLC**
- Source: MarketBeat | 20251216T120824 | Somewhat-Bullish | Relevance: 100%
- Shorepoint Capital Partners LLC has acquired 12,033 shares of NXP Semiconductors N.V. (NASDAQ:NXPI) during the third quarter, valued at approximately $2.74 million. Institutional ownership of NXPI is very high at 90.54%, with other major firms like Norges Bank and Wellington Management Group LLP also increasing their stakes. Despite recent insider share sales by two executive VPs, analysts maintain a "Moderate Buy" consensus rating with an average target price of $260.04, contrasting with the current trading price near $231.83.

**3. Congressional Stock Sales Under Scrutiny: Representative Julie Johnsonâ€™s NXP Semiconductors Transaction Ignites Debate**
- Source: Markets Financial Content | 20251215T140838 | Somewhat-Bearish | Relevance: 100%
- Representative Julie Johnson's sale of NXP Semiconductors shares has reignited the debate over congressional stock trading and potential conflicts of interest. The transaction, valued between $1,001 and $15,000, occurred on November 13, 2025, and was disclosed on December 11, 2025, falling within the existing STOCK Act framework. This event is prompting renewed calls for stricter ethics rules, potentially banning lawmakers from trading individual stocks, and underscores the broader implications for public trust and the integrity of financial markets.

**4. Rep. Julie Johnson Sells NXP Semiconductors N.V. (NASDAQ:NXPI) Shares**
- Source: MarketBeat | 20251215T132133 | Neutral | Relevance: 100%
- Representative Julie Johnson (D-Texas) recently sold between $1,001 and $15,000 in NXP Semiconductors N.V. (NASDAQ:NXPI) stock on November 13th, as disclosed in a December 11th filing. This sale was part of a series of transactions on the same date, involving other companies like Charles Schwab and UnitedHealth Group, all executed from her CHASE BROKERAGE ACCOUNT. The article also provides a financial overview of NXP Semiconductors, including its trading performance, recent earnings, dividend announcement, institutional trading activities, and analyst ratings.

**5. 8,736 Shares in NXP Semiconductors N.V. $NXPI Bought by Caldwell Trust Co**
- Source: MarketBeat | 20251215T091125 | Bullish | Relevance: 100%
- Caldwell Trust Co recently acquired 8,736 shares of NXP Semiconductors N.V. (NASDAQ:NXPI) valued at approximately $1,909,000, as disclosed in their latest SEC filing. This acquisition is part of broader institutional investor activity, with several other hedge funds also adjusting their positions in the semiconductor provider. The article also details recent insider transactions and analyst ratings, indicating a "Moderate Buy" consensus for NXP Semiconductors with an average price target of $260.04.

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 12 ($0.05M) |
| Sells | 22 ($3.36M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 60.5% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 4 |

**Top Holders:**
- JPMORGAN CHASE & CO: 19.1% (+111.9%)
- FMR, LLC: 9.5% (-3.6%)
- Blackrock Inc.: 8.3% (+1.8%)
- Vanguard Group Inc: 5.3% (-0.2%)
- Wellington Managemen: 5.0% (+11.9%)

### Key Risks

1. Insider selling cluster: $3.4M in recent transactions.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 1.27 suggests fair value with growth premium. Quality metrics strong (ROE 21%, margin 17%). Balance sheet: strong liquidity (2.4x). Insider selling cluster ($3.4M in 90 days), potential headwind. Institutional flow bullish (6 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $58.4B |
| Beta | 1.47 |
| 52W Range | $148.09 - $255.45 |
| Short Interest | 2.8% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.27 |
| Forward P/E | 16.9 |
| Current P/E | 19.7 |
| YoY Growth | 16.6% |
| EPS Direction | STABLE |

### Technicals

MRS_10 deteriorating from 6.1% to 3.9% (-2.3% in 5 days), indicating relative weakness vs NASDAQ. Currently in lower STRENGTH zone (3.0-6.0%), cross-sectional ranking at 71st percentile. MRS_5 at 2.4% confirms short-term momentum alignment. Outperforming sector by 4.3pp, stock-specific strength. Full SMA alignment bullish (above 20/50/200 SMAs). MACD histogram positive (3.09), confirming momentum. OFD pattern: +SBN (Volatile).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 3.86% (CS: 72) | Strong |
| RSI_14 | 67.8 | Neutral |
| MACD Histogram | 3.09 | Bullish |
| vs SMA20 | 1.106x | Above |
| vs SMA50 | 1.096x | Above |
| vs SMA200 | 1.101x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $231.83
- **Stop Loss:** $218.47 (5.8% risk)
- **Target:** $245.19 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 74
- **Position Value:** $17,155.42
- **Portfolio %:** 17.16%
- **Risk Dollars:** $1,000.00
- **Risk Per Trade:** 1.00%
- **Modifiers:** L1 100% | L2 100% | Combined 1.00x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with moderate risk appetite and mixed signals. VIX at moderate levels (16.5) with elevated put/call ratio suggesting cautious positioning, while normal yield curve and stable breadth indicate no systemic stress. Focus on selective opportunities with defensive positioning.*

### Earnings

**Next:** 2026-02-02 (Est: $3.30)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $3.12 | $3.11 | -0.3% |
| 2025Q2 | $2.66 | $2.72 | +2.3% |
| 2025Q1 | $2.60 | $2.64 | +1.4% |
| 2024Q4 | $3.14 | $3.18 | +1.4% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*